Chronic Disease Prevalence and Medicare Advantage Market Penetration
By March 2015, 30% of all Medicare beneficiaries were enrolled in Medicare Advantage (MA) plans. Research to date has not explored the impacts of MA market penetration on individual or population health outcomes. The primary objective of this study is to examine the relationships between MA market p...
Saved in:
Main Authors: | Steven W. Howard (Author), Stephanie Lazarus Bernell (Author), Faizan M. Casim (Author), Jennifer Wilmott (Author), Lindsey Pearson (Author), Caitlin M. Byler (Author), Zidong Zhang (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The association between Medicare Advantage market penetration and diabetes in the United States.
by: Steven W. Howard, et al.
Published: (2015) -
Improving Affordability and Equity in Medicare Advantage
by: Zirui Song MD, PhD, et al.
Published: (2019) -
Can Insurance Market Competition Coexist With Provider Price Regulation? Evidence From Medicare Advantage
by: Robert A. Berenson MD, et al.
Published: (2019) -
Mispricing in the Medicare Advantage Risk Adjustment Model
by: Jing Chen PhD, MBA, et al.
Published: (2015) -
What's Driving High Disenrollment in Medicare Advantage?
by: Eva DuGoff PhD, MPP, et al.
Published: (2019)